C
Brainsway Ltd. BWAY
$14.91 $0.000.00% NASDAQ
Recommendation
Prev Close
$14.91
Volume
71,262
Avg Vol (90D)
60,408
Market Cap
$290.50M
Dividend & Yield
--
52-Week Range
$7.84 - $17.00
P/E (TTM)
272.58
EPS (TTM)
$0.0547
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
FluoroPharma Medical (OTCMKTS:FPMI) and Brainsway (NASDAQ:BWAY) Head to Head Comparison
9/25/2025 - Ticker Report
BrainsWay (BWAY, $14.91) Aroon Indicator entered an Uptrend on September 24, 2025.
9/25/2025 - Tickeron - Stocks
BrainsWay (BWAY, $15.36) Aroon Indicator entered an Uptrend on September 23, 2025.
9/24/2025 - Tickeron - Stocks
BrainsWay (BWAY, $15.51) Aroon Indicator entered an Uptrend on September 22, 2025.
9/23/2025 - Tickeron - Technical Analysis
BrainsWay (BWAY, $15.42) Aroon Indicator entered an Uptrend on September 19, 2025.
9/20/2025 - Tickeron - Stocks
BrainsWay (BWAY, $15.96) entered Downtrend as Momentum indicator drops below 0 level on Sep 18, 2025
9/19/2025 - Tickeron - Technical Analysis
BrainsWay (BWAY, $15.96) Aroon Indicator entered an Uptrend on September 18, 2025.
9/19/2025 - Tickeron - Technical Analysis
BrainsWay (BWAY, $16.06) RSI Indicator left the overbought zone on September 17, 2025
9/18/2025 - Tickeron - Stocks
BrainsWay (BWAY, $16.06) Aroon Indicator entered an Uptrend on September 17, 2025.
9/18/2025 - Tickeron - Stocks
BrainsWay (BWAY, $16.89) RSI Indicator left the overbought zone on September 16, 2025
9/17/2025 - Tickeron - Stocks
BrainsWay (BWAY, $16.89) price may drop as it broke higher Bollinger Band on Sep 16, 2025
9/17/2025 - Tickeron - Stocks
BrainsWay (BWAY, $16.89) Aroon Indicator entered an Uptrend on September 16, 2025.
9/17/2025 - Tickeron - Stocks
BrainsWay (BWAY, $16.89) entered Uptrend as Momentum indicator ascends above 0 level on Sep 16, 2025
9/17/2025 - Tickeron - Stocks
FDA Clearance Boosts BrainsWay (BWAY) Shares
9/16/2025 - GuruFocus
BrainsWay rises as FDA clears accelerated Deep TMS protocol
9/16/2025 - Seeking Alpha - Israel Stocks
BrainsWay rises as FDA clears accelerated Deep TMS protocol
9/16/2025 - Seeking Alpha - Healthcare
BrainsWay rises as FDA clears accelerated Deep TMS protocol
9/16/2025 - SeekingAlpha.com: All News
BrainsWay (BWAY) Gains FDA Approval for Enhanced Depression Treatment Protocol
9/16/2025 - GuruFocus
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment ...
9/16/2025 - GuruFocus
BrainsWay Gains FDA Clearance for Accelerated Depression Treatment Protocol
9/16/2025 - TipRanks Financial Blog
Brainsway receives FDA clearance for accelerated Deep TMS for MDD
9/16/2025 - The Fly
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
9/16/2025 - Globe Newswire
BrainsWay (BWAY, $15.1) entered Downtrend as Momentum indicator drops below 0 level on Sep 15, 2025
9/16/2025 - Tickeron - Stocks
BrainsWay (BWAY, $15.1) Aroon Indicator entered an Uptrend on September 15, 2025.
9/16/2025 - Tickeron - Stocks
BrainsWay (BWAY, $15.77) Aroon Indicator entered an Uptrend on September 12, 2025.
9/13/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$41.02M
EBITDA (TTM)
$2.68M
EBIT (TTM)
$1.39M
Net Income (TTM)
$2.92M
Balance Sheet
Total Assets (Q)
$94.32M
Total Debt (Q)
$5.62M
Total Liabilities (Q)
$32.00M
Book Value Per Share (Q)
$1.66
Cash Flow
Cash from Operations (TTM)
$10.30M
Cash from Investing (TTM)
$30.31M
Cash from Financing (TTM)
$18.26M
Net Change in Cash (TTM)
$58.83M
Filings
Filing Date
Tuesday, April 22, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
(est)
Price History
Loading...
Beta
1.69
7-Day Total Return
-11.72%
30-Day Total Return
17.40%
60-Day Total Return
14.91%
90-Day Total Return
50.45%
Year to Date Total Return
55.64%
1-Year Total Return
80.51%
2-Year Total Return
253.32%
3-Year Total Return
321.19%
5-Year Total Return
155.53%
52-week Low
Apr 21, 2025 - $7.84
52-week High
Sep 16, 2025 - $17.00
Valuation
Market Cap
$290.50M - Micro Cap
Enterprise Value
$218.06M
Price/Sales (TTM)
14.07
Price/Book (Q)
9.00
Dividends and Shares
Shares Outstanding
38.70
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.brainsway.com
Phone Number
972 2 582 4030
Address
16 Hartum St
Jerusalem, 9777516
Country
Israel
Year Founded
2003
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic... more
NASDAQ 09/25/2025 4:00PM Eastern Quotes delayed